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Abstract
Background: Hip osteoarthritis (OA) is recognised as a substantial source of disability, with pain
and loss of function as principal symptoms. An aging society and a growing number of overweight
people, which is considered a risk factor for OA, contribute to the growing number of cases of hip
OA. In knee OA patients, exercise as a single treatment is proven to be very effective towards
counteracting pain and physical functionality, but the combination of weight loss and exercise is
demonstrated to be even more effective. Exercise as a treatment for hip OA patients is also
effective, however evidence is lacking for the combination of weight loss and exercise.
Consequently, the aim of this study is to get a first impression of the potential effectiveness of
exercise and weight loss in overweight patients suffering from hip OA.
Methods/Design: This is a prospective cohort study. Patients aged 25 or older, overweight (BMI
> 25) or obese (BMI > 30), with clinical and radiographic evidence of OA of the hip and able to
attend exercise sessions will be included. The intervention is an 8-month exercise and weight-loss
lifestyle program. Main goal is to increase aerobic capacity, lose weight and stimulate a low-calorie
and active lifestyle. Primary outcome is self-reported physical functioning. Secondary outcomes
include pain, stiffness, health-related quality of life and habitual activity level. Weight loss in
kilograms and percentage of fat-free mass will also be measured.
Discussion: The results of this study will give a first impression of potential effectiveness of
exercise and weight loss as a combination program for patients with OA of the hip. Once this
program is proven to be effective it may lead to postponing the moment of total hip replacement.
Trial Registration number: NTR1053
Background
Osteoarthritis (OA) is the most common joint disorder in
the world[1]. OA is recognized as a substantial source of
disability with significant social and financial costs due to
surgical and medical interventions and frequent absentee-
ism from work. OA of the lower limb is primarily concen-
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trated in the hip and knee joint. Pain is the principal
symptom of OA. At first it occurs after use of the joint, and
is relieved by rest. In later stages of OA, pain may be
present during rest and even sleep. Other symptoms of
OA include stiffness following rest and instability of the
joint[2,3].
Most recent numbers from the US (1990) show incident
rates of OA of the hip of 0.5 per 1000 per year[4]. In the
Netherlands the incidence in 2000 was 1.25 per 1000 per
year[5], and its prevalence will increase with the aging of
Western society[6,7]. In Europe, the percentage of people
over 65 years was 17% in the year 2004. Although at 14%
the Netherlands is still below this percentage, it is
expected to increase to 24% by the year 2050[8]. For this
reason, the number of people with OA of the hip in the
Netherlands is expected to increase by 1.8 to 4.3% in the
period 2004–2024[6]. A similar trend is seen world-
wide[9,10].
An additional risk factor for OA is being overweight or
obese[11]. Being overweight is defined as having a Body
Mass index (BMI) of 25–30 kg/m2, and being obese as
having a BMI of 30 kg/m2 or more. An increase of over-
weight or obese people is seen not only in America[12]
but in Europe as well [13-15]. In the Netherlands in 2007,
45.5% of adults were overweight or obese[16]. Results
from the 2003–2004 National Health and Nutrition
Examination Survey (NHANES) indicate that 66% of
American adults are either overweight or obese[17]. In
this respect, not only the number of older people contrib-
utes to the increase of patients with hip OA, but the
number of overweight or obese people as well.
To date, conservative treatment modalities for OA of the
lower limb have focused on pain relief and preservation of
joint function[7,18]. In these modalities, modification of
lifestyle factors such as physical inactivity and overweight/
obesity is considered a core element[7,19]. With respect to
the treatment of OA of the knee, it has been proven that
modification of physical inactivity and obesity is an effec-
tive conservative treatment modality. Weight loss as a sin-
gle therapy reduces symptoms of OA of the knee[20,21],
and therapeutic exercise induces the same effect[7]. Com-
bining these two treatments shows even more effect on
pain and functionality in knee OA[22]. However, with
respect to the treatment of OA of the hip this evidence is
lacking. Previously conducted studies have focussed
mainly on knee OA, or the combination of knee and hip
OA, without distinguishing by joint[23]. One Cochrane
review, which did distinguish by joint, found that exercise
treatments designed to reduce pain and improve function-
ing were effective in knee OA patients, but the same con-
clusion could not be drawn for hip OA patients due to
insufficient data[24].
The aim of this prospective cohort study is thus to get a
first glimpse of the potential effectiveness of a combina-
tion program of exercise and weight loss on overweight
and obese patients suffering from hip OA.
Methods/design
Study design
A prospective cohort study will be conducted at the
department of orthopaedics of University Medical Center
Groningen (UMCG) in collaboration with the Allied
Health Care Center for Rheumatology Rehabilitation
(AHCRR) Hilberdink. The study design, procedures and
informed consent are approved by the Medical Ethics
Committee of UMCG.
Identification and recruitment of study participants
Patients aged 25 or older, with clinical and radiographic
evidence of OA of the hip who are also overweight (BMI >
25) or obese (BMI > 30) will be included. A BMI of 40 will
be used as the upper limit. The clinical evidence of hip OA
is based on the definition determined by Altman et al.
(1991): a) hip internal rotation ≥ 15°, pain with internal
rotation of the hip, morning stiffness of the hip for ≤ 60
minutes, or b) hip internal rotation < 15° and hip flexion
of ≤ 115°, which has a sensitivity of 86% and a specificity
of 75%. The radiographic diagnosis for OA of the hip will
be established by means of the Kellgren and Lawrence cri-
teria[25], of which grade 1–3 will be included.
Exclusion will be based on conditions which prevent safe
participation in an exercise program (angina pectoris,
peripheral vascular disease, stroke, congestive heart fail-
ure, chronic obstructive pulmonary disease, insulin-
dependent diabetes, psychiatric disease, renal disease,
liver disease, active cancer other than skin cancer and
anaemia); problems of the foot or ankle that could inter-
fere with an exercise program; rheumatic arthritis; an ina-
bility to walk without a cane or other assistive device;
participation in another research study; inability to finish
the study or unlikely to be compliant with the opinion of
the clinical staff because of frailty or illness; inability to fill
in a questionnaire as a result of language problems or
dementia. The assessment to include or exclude will be
determined by the orthopaedic specialist or the general
practitioner.
Recruitment will originate from three sources: 1) the out-
patient OA clinic of the Orthopaedic Department of
UMCG or the Orthopaedic Department of Martini Hospi-
tal Groningen; 2) general practices in the local area of the
AHCRR and at the Department of General Practice of
UMCG; and 3) patients who present themselves directly at
the AHCRR and meet the inclusion criteria, as established
by their general practitioner (see figure 1). Patients withBMC Musculoskeletal Disorders 2009, 10:24 http://www.biomedcentral.com/1471-2474/10/24
Page 3 of 9
(page number not for citation purposes)
Identification and recruitment of study participants Figure 1
Identification and recruitment of study participants.
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hip OA who meet the inclusion criteria and are not yet
indicated for hip replacement are invited to participate.
Intervention
The intervention is an 8-month exercise and weight-loss
combination program under the supervision of physio-
therapists and a dietician at the AHCRR, and will be pre-
sented to the patient as a lifestyle program.
The exercise portion consists of an individual 3-month
part and a 5-month group session part. The individual
part consists of defining and improving the physical load
potential of the patient, reducing current disabilities like
lack of joint mobility and stability, optimising quality of
movement, improving illness perceptions and enhancing
physical fitness. The group part is focused on teaching
self-management and coping, stimulating an active life-
style, finding an optimal balance between exertion and
relaxation, increasing aerobic capacity and physical fit-
ness, increasing muscle strength, and decreasing limita-
tions of activities of daily living. Aerobic capacity and
physical fitness improvement will be achieved with the
help of various devices like treadmills, free weight
benches, stationary exercise bikes, steppers and/or rowing
machines. All exercises will focus on personal needs, and
personal preferences for aerobic equipment will be taken
into consideration. A weekly exercise session lasts approx-
imately 1 hour. In addition, patients are urged to achieve
a minimum of 30 minutes of moderately intense physical
activity on most, preferably all days of the week, in order
to comply with national/international physical activity
guidelines [26-28]. At the beginning of every exercise ses-
sion patients are asked for their activities of last week.
Parallel to the individual and group phase of the exercise
program, the weight-loss program is implemented by a
certified dietician. This diet part of the intervention is
based on principles of social cognitive theory, which
argues for the important role of cognitive control systems
in the acquisition of behavioural proficiencies[29]. The
weight loss program is divided into three phases: an inten-
sive, a transition and a maintenance phase in concordance
with Messier et al[22]. The main goal of the first phase is
to heighten awareness of the importance of and need for
changing eating habits. In this phase the ability to read
and understand the diversity of labels in food products
will be enhanced, and the patient will set goals he believes
he can achieve. In the transition phase, problems the
patient encounters will be discussed and self-insight will
be enhanced concerning the choices that can be made
when buying food. Goal in this phase is to prevent
relapse. Finally, in the maintenance phase the main objec-
tive is to maintain the achieved weight loss and to pre-
serve the motivation to keep on going with the healthy
eating habits. Adherence to the intervention is based on
attendance at scheduled sessions.
In addition to the combination program (exercise and
weight loss), patients receive a manual consisting of writ-
ten information that focuses on health education, includ-
ing topics about the medical background of OA, OA
treatments, and coping with chronic pain.
Sample size
Considering the calculation of the sample size, the study
of Messier[22] is used as a reference. In this study Messier
showed that a combination of exercise and weight reduc-
tion in patients with OA of the knee led to a significant
improvement (α < 0.05) on the primary outcome meas-
ure of self-reported physical function. In order to find an
analogous improvement of self-reported physical func-
tion of approximately 25% between the first (T0) and last
measurements (T2) in patients with OA of the hip, a min-
imum of 20 patients is needed. This number is based on a
power (1-B) of 0.80 and a significance level of 5% (two-
sided). When a dropout rate of 20% is taken into account,
at least 25 participants have to be included.
Outcome measurements
At baseline (T0), information is gathered about the
patients' demographics (educational level, marital status,
family composition) and comorbidities as well as about
medication and supplemental use.
Primary outcome measurement
The Western Ontario and McMaster Universities Osteoarthri-
tis Index (WOMAC): self-reported physical functioning is
the primary outcome measure, to be measured with the
physical function subscale of the Dutch version of the
WOMAC (Dutch-WOMAC)[30,31]. The WOMAC Index
is a disease-specific measure of health status and is widely
used and recommended in OA research. The validity, reli-
ability and responsiveness of this measure have been
demonstrated in an extensive range of studies[32]. The
Dutch version of the WOMAC has also been considered
valid, reliable and reproducible[31]. The Dutch WOMAC
consists of three dimensions: pain (5 items), stiffness (2
items) and physical functioning (17 items). Responses on
the 24 items are given on a 5-point Likert scale. All scores
will be recoded into a 100-point scale, indicating a score
of 0 as the worst possible health condition and 100 the
best possible health score.
Secondary Outcome measurements
To add information about the potential effectiveness of
the intervention, participants will be assessed using a
range of standardised, self-report measures that include:BMC Musculoskeletal Disorders 2009, 10:24 http://www.biomedcentral.com/1471-2474/10/24
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1. Western Ontario and McMaster Universities Osteoarthritis
Index (WOMAC): the other two dimensions of the Dutch
WOMAC, pain and stiffness.
2. Short Form Health Survey (SF-36): the SF-36 measures
health-related quality of life and is considered to be valid,
reliable and reproducible[33]. The SF-36 is composed of
36 questions, organised into 8 multi-items scales: physical
functioning, role limitations due to physical health prob-
lems, bodily pain, general health perceptions, vitality,
social functioning, role limitations due to emotional
problems and general mental health[33].
3. Short QUestionnaire to ASsess Health enhancing physical
activity (SQUASH): The SQUASH is designed to give an
indication of habitual activity level. The SQUASH consists
of 6 main questions and is subdivided in 4 categories: (A)
commuting activities, (B) leisure-time activities, (C)
household activities, and (D) activities at work and
school. With the help of the Ainsworth compendium of
physical activities[34], the SQUASH subdivides activities
into three intensity categories for adults and for older
adults (up to age 55 and older). These intensity categories
are determined by MET values. MET stands for metabolic
equivalent and is defined as 'the ratio of the work meta-
bolic rate to the resting metabolic rate'. For adults, inten-
sity of activities with a MET-value between 2 and < 4 was
classified as light, between 4 and < 6.5 as moderate, and ≥
6.5 as vigorous. For older adults, intensity of activities
between 2 and < 3 MET was classified as light, between 3
and < 5 MET as moderate, and ≥ 5 MET as vigorous.
Activities with a MET-value lower than 2 will not be ana-
lysed because they are considered to contribute negligibly
to habitual activity level. The SQUASH is structured in
such a way that it is also possible to assess compliance
with physical activity guidelines. The SQUASH is proven
to be a fairly reliable and reasonably valid question-
naire[35]. The measurement properties of the SQUASH
have been assessed in a population of adults, where it
showed an overall reproducibility of 0.58 (95%-CI 0.36–
0.74). The relative validity in this study was 0.45 (95%-CI
0.17–0.66) [35]. In a population of overweight peo-
ple[36] and of people after total hip arthroplasty[37], the
Squash was validated with use of an accelerometer with a
correlation of 0.40 (p = 0.05) and 0.67 (p = 0.01) respec-
tively. Furthermore, Spearman's correlation coefficient for
overall reliability in the overweight study was not applica-
ble, but the hip arthroplasty study showed a value of 0.57
(95%-CI 0.35–0.73)[37].
Patients will also be evaluated using objective measure-
ments, which include:
1. 6-Minute Walk Test (6 MWT). The 6 MWT is a functional
walking test developed to measure functional status[38].
The test provides information about gait speed and func-
tional and endurance capacity. The primary outcome is
the total distance walked. The 6 MWT is considered a reli-
able test [39,40].
2. 20-Meter Walk Test (20 MWT). The 20 MWT is a short,
safe test used to measure gait speed like the 10
MWT[41,42]. Patients walk indoors on a 20-m long track,
and the time spent to complete the walk (in seconds) will
be measured. Time recording will be accomplished with
electronic timing equipment by means of photocell gates
(HL 2–31 Photocell, Tagheuer, la Chaux-de-Fond, Swit-
zerland).
3. Weight and fat-free mass assessment. The amount of lost
weight and the amount of fat-free mass can give an indi-
cation of improvement of the overweight problem.
Weight will be measured with a calibrated scale, always
performed by the same dietician. The fat-free mass meas-
urement will be assessed by a hand-held impedance ana-
lyser (Omron Body Fat Monitor, model BF 306). It is
concluded that the Omron BF 306 body fat monitor
yielded results close to the DEXA Body Fat%[43].
4. Compliance with the program. Compliance will be regis-
tered by AHCRR diet and exercise session attendance. This
attendance will be assessed by dividing number of exer-
cise sessions participants actually attended by the number
of sessions participants were asked to attend, multiplied
by 100%.
The first measurement will take place before the combina-
tion program begins (T0). The second measurement (T1)
will take place at the beginning of the exercise group por-
tion of the combination program after 3 months, and the
third measurement (T2) at the end of the combination
program after 8 months (see figure 2).
Statistical analysis
All statistical analyses will be computed using the Statisti-
cal Package for the Social Sciences (SPSS, Inc., Version
16.0, 2007, Chicago). Descriptive statistics will be used to
describe the group. Changes in response outcomes from
measurement points T0 to T2 will be assessed with the
GLM ANOVA repeated measurements analyses. Changes
in outcomes between measurement points T0 and T2
(pre- and post-measurement) will be analysed with a
paired samples T-test. For all test procedures, a probability
value of less than 0.05 will be considered as statistically
significant.BMC Musculoskeletal Disorders 2009, 10:24 http://www.biomedcentral.com/1471-2474/10/24
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Study design and assessment points Figure 2
Study design and assessment points. T0 = start of the combination program, T1 = 3 months, T2 = 8 months, end of the 
program.
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Time frame
This study has an 18-month time frame. It is anticipated
that identification of potential study participants and
recruitment will commence in January 2009. Data analy-
sis will be performed in February 2010 and the final
report will be drafted afterwards.
Discussion
The objective of this prospective cohort study is to get a
first glimpse of the potential effectiveness of exercise and
weight loss on overweight patients suffering from hip OA.
If this study indeed demonstrates that the proposed com-
bination program seems to be effective for hip osteoar-
thritis, it will be followed by a randomised controlled trial
(RCT). In this RCT the effectiveness of the combination
program will be investigated in a more controlled setting
and will also include a closer look at the cost effectiveness
of the combination program. Potential effectiveness of the
combination program implies benefits for patients as well
as society.
Patient benefits
A potential benefit for the patient is that the moment of
joint replacement can be postponed. Although technical
developments have prolonged the lifecycle of hip prosthe-
ses, a prosthesis tends to be replaced after a mean of 10
years[44] (what is known as a revision). Revision surgery
has greater risks than primary surgery, such as an
increased chance of septic loosening. Especially in the case
of young people, this is an important reason to postpone
a total joint replacement. Conservative therapy (e.g. exer-
cise in combination with weight loss) can therefore be a
valuable tool towards accomplishing this[45], and
although scientific evidence is lacking, structured exercise
and weight loss are already recommended in the clinical
setting as a conservative treatment option for patients
with OA of the hip[46].
Secondly, regular physical activity can have a positive
effect on the general health and fitness of the patient.
There is a known dose-response relation between physical
activity and health, and according to the recommenda-
tions of the ACSM is it important to promote physical
activity in older adults that emphasises moderate-inten-
sity aerobic activity and muscle-strengthening activ-
ity[26,28]. Regular physical activity has been consistently
and reliably linked to a reduction in all-cause mortality,
cardiovascular disease and many other debilitating condi-
tions[28]. In addition to the beneficial effects of physical
activity on health, regular physical activity also increases
older adults' ability to perform their daily activities, thus
enhancing their quality of life[47].
In case of weight loss, health benefits are observed in
patients with OA in the form of reduced self-reported dis-
ability[20] and improved self-reported physical func-
tion[20,22]. Published reviews in the obesity literature
indicate that obesity impairs health-related quality of life
(HRQL) and that higher degrees of obesity are associated
with greater impairment[48]. Rejeski[47] pursued this
subject in patients with OA, demonstrating that lifestyle
modifications like dietary and physical activity behav-
iours are important interventions for enhancing HRQL
[47]. Additionally, weight loss has induced positive
improvements in sexual quality of life dimensions[49],
which can also be considered as important in the overall
rating of quality of life.
Social benefits
In light of the forecasts of a sharp accumulation of
patients with OA, the potential effectiveness of the pro-
posed combination program provides substantial social
benefits. This conservative program, considered as life-
style management, can assist in the approach towards
dealing with the large number of people with hip osteoar-
thritis and most probably reduce the medical costs these
patients incur, like physician appointments, medication,
outpatient clinical visits and physiotherapy. Eventually,
research into the combination of exercise and weight loss
in overweight and obese patients suffering from hip OA
can provide government agencies and social insurance
organisations with evidence to incorporate this kind of
therapy for hip osteoarthritis into medical insurance pack-
ages. The positive effects of the combination program
could end up supporting referral to the program by clini-
cians caring for people with OA of the hip.
In conclusion, this study will provide highly relevant data
on the potential effect of exercise and weight reduction
among people suffering from OA of the hip.
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